These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7622821)

  • 1. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S; Möller HJ; Montgomery SA; Zondag E
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of fluvoxamine in patients with severe depression.
    Ottevanger EA
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):731-40. PubMed ID: 7938563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD
    Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
    J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.